Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Combinations of DMARDs are currently used to treat rheumatoid arthritis by almost all rheumatologists. This article reviews the published data on the triple combination of methotrexate, sulfasalazine, and hydroxychloroquine, discusses caveats for clinical use, compares efficacy of different combinations, and speculates on future combination therapies.

Original languageEnglish (US)
Pages (from-to)465-477
Number of pages13
JournalRheumatic Disease Clinics of North America
Volume24
Issue number3
DOIs
StatePublished - 1998

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis'. Together they form a unique fingerprint.

  • Cite this